Summary

उपगोल TGF-β प्रेरित आक्रमण उपाय परख

Published: November 16, 2011
doi:

Summary

मात्रात्मक ग्रोथ फैक्टर (TGF) β प्रेरित 3 आयामी कोलेजन जैल में आक्रमण बदलने को मापने के लिए एक परख वर्णित है. यह परख सेल लाइनों के MCF10A श्रृंखला है, जो स्तन कैंसर के विकास के विभिन्न चरणों का प्रतिनिधित्व करते हैं का लाभ लेता है. इस विधि के अन्य सेल लाइनों के साथ इस्तेमाल किया जा और अन्य संभावित activators या आक्रमण की inhibitors की जांच करने के लिए इस्तेमाल किया जा सकता है अपनाया जा सकता है.

Abstract

TGF-β has opposing roles in breast cancer progression by acting as a tumor suppressor in the initial phase, but stimulating invasion and metastasis at later stage1,2. Moreover, TGF-β is frequently overexpressed in breast cancer and its expression correlates with poor prognosis and metastasis 3,4. The mechanisms by which TGF-β induces invasion are not well understood.

TGF-β elicits its cellular responses via TGF-β type II (TβRII) and type I (TβRI) receptors. Upon TGF-β-induced heteromeric complex formation, TβRII phosphorylates the TβRI. The activated TβRI initiates its intracellular canonical signaling pathway by phosphorylating receptor Smads (R-Smads), i.e. Smad2 and Smad3. These activated R-Smads form heteromeric complexes with Smad4, which accumulate in the nucleus and regulate the transcription of target genes5. In addition to the previously described Smad pathway, receptor activation results in activation of several other non-Smad signaling pathways, for example Mitogen Activated Protein Kinase (MAPK) pathways6.

To study the role of TGF-β in different stages of breast cancer, we made use of the MCF10A cell system. This system consists of spontaneously immortalized MCF10A1 (M1) breast epithelial cells7, the H-RAS transformed M1-derivative MCF10AneoT (M2), which produces premalignant lesions in mice8, and the M2-derivative MCF10CA1a (M4), which was established from M2 xenografts and forms high grade carcinomas with the ability to metastasize to the lung9. This MCF10A series offers the possibility to study the responses of cells with different grades of malignancy that are not biased by a different genetic background.

For the analysis of TGF-β-induced invasion, we generated homotypic MCF10A spheroid cell cultures embedded in a 3D collagen matrix in vitro (Fig 1). Such models closely resemble human tumors in vivo by establishing a gradient of oxygen and nutrients, resulting in active and invasive cells on the outside and quiescent or even necrotic cells in the inside of the spheroid10. Spheroid based assays have also been shown to better recapitulate drug resistance than monolayer cultures11. This MCF10 3D model system allowed us to investigate the impact of TGF-β signaling on the invasive properties of breast cells in different stages of malignancy.

Protocol

1. Methocel समाधान तैयार करना (500 एमएल) आटोक्लेव एक 500 मिलीलीटर एक चुंबकीय उत्तेजक युक्त बोतल में 6 methylcellulose के जी. सीरम (60 ° सी) के बिना 20 मिनट के लिए preheated DMEM/F12 की 250 मिलीलीटर में methylcellulose भंग. DMEM/F12 (आरटी) 10% घोड़े सीरम ?…

Discussion

हम एक उपगोल मॉडल में जो MCF10A1 कोशिकाओं और उसके घातक डेरिवेटिव TGF-β निर्भर तरीके में एक मैट्रिक्स कोलेजन में आक्रमण की स्थापना की. सबसे पहले, spheroids methylcellulose की उपस्थिति में 96 कुओं दौर नीचे निलंबन प्लेटों में बनते ?…

Divulgations

The authors have nothing to disclose.

Acknowledgements

हम केन और अभिकर्मकों फ्रेड मिलर (बारबरा Ann Karmanos कैंसर Intitute, डेट्रोइट, संयुक्त राज्य अमेरिका) सेल लाइनों के लिए के लिए Iwata (OSI फार्मास्यूटिकल्स, न्यू यार्क, संयुक्त राज्य अमेरिका) के लिए आभारी हैं.

Materials

Name of the reagent Company Catalogue number Comments (optional)
Methyl cellulose Sigma-Aldrich M0512  
PureCol Advanced Biomatrix 5005-B  
pH indicator strips Merck 9533  
96-well suspension
plates
Greiner Bio-one 650 185  
96-well adhesion TC
plates
Greiner Bio-one 655 180  

References

  1. Akhurst, R. J., Derynck, R. TGF-β signaling in cancer–a double-edged sword. Trends. Cell. Biol. 11, S44-S51 (2001).
  2. Massagué, J. TGF-β in Cancer. Cell. 134, 215-215 (2008).
  3. Ghellal, A. Prognostic significance of TGF-β1 and TGF-β in human breast carcinoma. Anticancer. Res. 20, 4413-4413 (2000).
  4. Sheen-Chen, S. M. Serum levels of transforming growth factor-β1 in patients with breast cancer. Arch. Surg. 136, 937-937 (2001).
  5. ten Dijke, P., Hill, C. S. New insights into TGF-β-Smad signaling. Trends Biochem. Sci. 29, 265-265 (2004).
  6. Moustakas, A., Heldin, C. H. Non-Smad TGF-β signals. J. Cell Sci. 118, 3573-3573 (2005).
  7. Soule, H. D. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6075 (1990).
  8. Strickland, L. B. Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Cancer Res. Treat. 64, 235-235 (2000).
  9. Santner, S. J. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65, 101-101 (2001).
  10. Smalley, K. S., Lioni, M., Herlyn, M. Life isn’t flat: taking cancer biology to the next dimension. In Vitro Cell Dev. Biol. Anim. 42, 242-242 (2006).
  11. Kobayashi, H. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Natl. Acad. Sci. U. S. A. 90, 3294-3294 (1993).
  12. Inman, G. J. SB-431542 is a potent and specific inhibitor of transforming growth factor-b superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-65 (2002).
  13. Wiercinska, E. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res. Treat. 128, 657-657 (2011).
  14. Tang, B. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 112, 1116-1116 (2003).
  15. Provenzano, P. P. Collagen density promotes mammary tumor initiation and progression. BMC. Med. 6, 11-11 (2008).
  16. Ramaswamy, S. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-49 (2003).
  17. Debnath, J., Brugge, J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer. 5, 675-675 (2005).
  18. Pampaloni, F., Reynaud, E. G., Stelzer, E. H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell. Biol. 8, 839-839 (2007).
  19. Lee, G. Y. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods. 4, 359-359 (2007).
  20. Petersen, O. W. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 89, 9064-9064 (1992).
  21. Debnath, J., Muthuswamy, S. K., Brugge, J. S. Morphogenesis and oncogenesis of MCF10A mammary epithelial acini grown in three-dimensional basement membrane cultures. 30, 256-256 (2011).
  22. Li, Q. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer. 10, 314-314 (2011).
  23. Li, Q., Chow, A. B., Mattingly, R. R. Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors. J. Pharmacol. Exp. Ther. 332, 821-821 (2010).
check_url/fr/3337?article_type=t

Play Video

Citer Cet Article
Naber, H. P., Wiercinska, E., ten Dijke, P., van Laar, T. Spheroid Assay to Measure TGF-β-induced Invasion. J. Vis. Exp. (57), e3337, doi:10.3791/3337 (2011).

View Video